Indirect Treatment Comparison of the Efficacy and Safety of Sarilumab Monotherapy in Rheumatoid Arthritis Patients with Inadequate Response to Conventional Disease-Modifying Antirheumatic Drugs

被引：0
|
作者：
Ernest Choy
Nick Freemantle
Clare Proudfoot
Chieh-I Chen
Laurence Pollissard
Andreas Kuznik
Hubert van Hoogstraten
Erin Mangan
Paulo Carita
Thi-Minh-Thao Huynh
机构：
[1] Cardiff University,
[2] University College London,undefined
[3] Formerly of Sanofi,undefined
[4] Regeneron Pharmaceuticals,undefined
[5] Inc.,undefined
[6] Sanofi France,undefined
[7] Sanofi,undefined
来源：
Advances in Therapy | 2019年 / 36卷
关键词：
Biologic disease-modifying antirheumatic drugs; Network meta-analysis; Rheumatoid arthritis; Rheumatology; Sarilumab monotherapy;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：817 / 827
页数：10
相关论文
共 50 条
  • [31] Safety and Efficacy of Biological Disease-Modifying Antirheumatic Drugs in Older Rheumatoid Arthritis Patients: Staying the Distance
    Ishchenko, Alla
    Lories, Rik J.
    [J]. DRUGS & AGING, 2016, 33 (06) : 387 - 398
  • [32] PARTICULARITIES OF TREATMENT WITH CONVENTIONAL SYNTHETIC DISEASE-MODIFYING ANTIRHEUMATIC DRUGS (DMARDs) IN A GROUP OF PATIENTS WITH RHEUMATOID ARTHRITIS
    Schiotis, Ruxandra Elena
    Gosa, Dana
    Bocsan, Corina
    Suciu, Soimita
    Buzoianu, Anca Dana
    [J]. FARMACIA, 2017, 65 (03) : 479 - 484
  • [33] DISEASE-MODIFYING ANTIRHEUMATIC DRUGS (DMARD) IN THE TREATMENT OF PATIENTS WITH RHEUMATOID-ARTHRITIS
    HALBERG, P
    [J]. SCANDINAVIAN JOURNAL OF RHEUMATOLOGY, 1986, : 55 - 57
  • [34] Treatment adherence to disease-modifying antirheumatic drugs in Chinese patients with rheumatoid arthritis
    Xia, Yunfei
    Yin, Rulan
    Fu, Ting
    Zhang, Lijuan
    Zhang, Qiuxiang
    Guo, Genkai
    Li, Liren
    Gu, Zhifeng
    [J]. PATIENT PREFERENCE AND ADHERENCE, 2016, 10 : 735 - 742
  • [35] EFFICACY AND SAFETY OF UPADACITINIB IN A CHINESE SUBGROUP OF PATIENTS WITH RHEUMATOID ARTHRITIS AND INADEQUATE RESPONSE TO CONVENTIONAL SYNTHETIC DISEASE-MODIFYING ANTI-RHEUMATIC DRUGS
    Zeng, X.
    Liu, Y.
    Hu, J.
    Li, J.
    Wang, Y.
    Zhao, D.
    Wu, L.
    Xiao, Z.
    Li, Z.
    Xu, J.
    Meerwein, S.
    Xie, Y.
    Liang, P.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2022, 81 : 1324 - 1324
  • [36] Efficacy of tocilizumab in patients with moderate to severe active rheumatoid arthritis and a previous inadequate response to disease-modifying antirheumatic drugs: the ROSE study
    Yazici, Yusuf
    Curtis, Jeffrey R.
    Ince, Akgun
    Baraf, Herbert
    Malamet, Raymond L.
    Teng, Lichen L.
    Kavanaugh, Arthur
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2012, 71 (02) : 198 - 205
  • [37] Sustained Response in a Phase 3 Study of Sarilumab Plus Nonbiologic Disease-Modifying Antirheumatic Drugs in Patients with Active, Efficacy of Sarilumab in Combination with Csdmards in Patients with Rheumatoid Arthritis and Inadequate Response to TNF Inhibitors By Baseline Levels of Disease Activity
    Fleischmann, Roy
    van Hoogstraten, Hubert
    Jayawardena, Shyamalie
    Mangan, Erin K.
    Ching, Daniel
    Burmester, Gerd R.
    [J]. ARTHRITIS & RHEUMATOLOGY, 2017, 69
  • [38] COMPARATIVE EFFICACY OF NOVEL DISEASE-MODIFYING ANTIRHEUMATIC DRUGS AS MONOTHERAPY AND IN COMBINATION WITH METHOTREXATE IN RHEUMATOID ARTHRITIS PATIENTS WITH AN INADEQUATE RESPONSE TO TRADITIONAL DMARDS: A NETWORK META-ANALYSIS
    Buckley, Felicity
    Finckh, Axel
    Huizinga, Tom W. J.
    Dejonckheere, Fred
    Jansen, Jeroen P.
    [J]. RHEUMATOLOGY, 2014, 53 : 88 - 89
  • [39] Effects Of Tocilizumab On Serum Cytokines In Rheumatoid Arthritis With An Inadequate Response To Disease-Modifying Antirheumatic Drugs.
    Lee, Sang Jin
    Kim, Kyung Rok
    Joo, Sang Hyun
    Lee, Jae Myung
    Choi, In Ah
    Lee, Joo Youn
    Yoo, Hyun Jung
    Lee, Eun Young
    Lee, Eun Bong
    Park, Won
    Park, Sung Hwan
    Shim, Seung-Cheol
    Yoo, Dae-Hyun
    Baek, Han Joo
    Kim, Hyun Ah
    Lee, Soo Kon
    Lee, Yun Jong
    Park, Young Eun
    Cha, Hoon-Suk
    Song, Yeong Wook
    [J]. ARTHRITIS AND RHEUMATISM, 2013, 65 : S611 - S611
  • [40] TOCILIZUMAB AS MONOTHERAPY OR WITH ADD-ON DISEASE-MODIFYING DRUGS IN RHEUMATOID ARTHRITIS PATIENTS WITH INADEQUATE RESPONSE TO PREVIOUS TREATMENTS
    Bykerk, Vivian
    Ostor, Andrew J.
    Roman Ivorra, Jose
    Wollenhaupt, Jurgen
    Stancati, Andrea
    Bernasconi, Corrado
    Sibilia, Jean
    [J]. RHEUMATOLOGY, 2012, 51 : 135 - 135
12345